patients who acquired septic shock early during their ICU stay had a higher degree of illness severity and more severe organ dysfunction, yet outcome was better. Such differences may influence the ...
In AdrenOSS-2, which recruited 301 patients across 24 active European sites, septic shock patients with elevated ADM (>70 pg/ml) received Adrecizumab at either 4 mg/kg or 2 mg/kg, or placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback